'. PHP_EOL; } elseif ( strpos( $page_path, "deutsch") !== false) { echo ''. PHP_EOL; } elseif ( strpos( $page_path, "francais") !== false) { echo ''. PHP_EOL; } elseif ( strpos( $page_path, "italiano") !== false) { echo ''. PHP_EOL; } ?>

Technology Trends for Life Sciences Manufacturers

by , , , | Apr 17, 2018 | Industry, Life Sciences & Medical

Jim Cahill

Jim Cahill

Chief Blogger, Social Marketing Leader

We seem to be fully in the swing of industry conferences. This week is the pharmaceutical and biotech manufacturing industries’ INTERPHEX conference in New York City. It:

…brings over 11,000 global industry professionals and 650+ leading suppliers together to “Learn It, Experience It, Procure It” through a combination of no cost technical conference, exhibits, demonstrations, and networking events to leverage quality, efficiency and cost effectiveness in today’s ever-changing global market.

If you’ll be there, make sure to catch these presentations:

  • Automation Trends Facing the Industry – Wed, 4/18, 11:15am-12:00pm – Interphex Live, Crystal Palace CP-2 – Featuring Peter Zornio, Chief Technology Officer Emerson Automation Solutions
  • Technology Keynote Series: Information Technology Trends and Best Practices – Data Integrity and Process Security – Wed, 4/18, 11:45am – 12:30pm – Interphex Innovation Stage – Featuring a panel of industry experts including Bob Lenich, Life Sciences Marketing Director Emerson Automation Solutions
  • Predictive Maintenance Leveraging IIoT Technology Can Become Your Competitive Advantage – Thurs, 4/19, 11:30am – 12:15pm – Technical Conference Stage 1, Booth 1076, Exhibit Hall – Featuring Niv Weisenberg, Sr. Reliability Consultant, Emerson Automation Solutions

Emerson’s Bob Lenich and Michalle Adkins will also be at the Interphex conference. They’ve recently written an article for Pharma Bio World, Leverage the Industry 4.0 Revolution to Meet Market Challenges.

They open describing changes in the markets for manufacturers in the Life Sciences:

But with increasing levels of complexity and increased competition in the market, Life Sciences manufacturing is going through a transformation.

More flexibility is required:

Companies have increased expectations for real-time release and for more visibility to all the manufacturing activity, data collection, and analysis. Including the growing requirements from increasing regulatory scrutiny and cyber security means improved quality controls, better system management, and more access to data.

This highly-regulated industry has:

…been very cautious in adopting new technologies. With high costs to re-validate a working, licensed manufacturing process after making a change, the regulatory environment has historically been a major barrier.

Emerson booth 3453 at Interphex 2018

Manufacturers are developing strategic manufacturing roadmaps to overcome these barriers and have the flexibility and cost effectiveness to meet their business objectives. Two areas of strategic focus include throughput improvements and manufacturing flexibility.

Read the article for specific ways technologies and changing work practices are being incorporated to execute these strategies.

To see some of these thoughts in action, visit the Emerson team at Interphex in Booth 3453 to discuss ways that technology, people and work processes can help improve quality, efficiency and overall cost effectiveness in your manufacturing operations.

Find out more in the Life Science & Medical area of Emerson.com and/or connect and interact with other pharmaceutical and biotech manufacturing industry experts in the Life Sciences group in the Emerson Exchange 365 community.

Popular Posts


Related Posts

Follow Us

We invite you to follow us on Facebook, LinkedIn, Twitter and YouTube to stay up to date on the latest news, events and innovations that will help you face and solve your toughest challenges.

Do you want to reuse or translate content?

Just post a link to the entry and send us a quick note so we can share your work. Thank you very much.

Our Global Community

Emerson Exchange 365

The opinions expressed here are the personal opinions of the authors. Content published here is not read or approved by Emerson before it is posted and does not necessarily represent the views and opinions of Emerson.